Navigation Links
Global Multiple Sclerosis Drugs Market 2014-2018: Key Vendors are Bayer, Biogen Idec, Merck Serono, Novartis and Teva Pharmaceutical
Date:8/29/2014

rugs used for the treatment of multiple sclerosis.

The report, the Global Multiple Sclerosis Drugs Market 2014-2018, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and the APAC and EMEA regions; it also covers the Global Multiple Sclerosis Drugs market landscape and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market.

Key Topics Covered:

01. Executive Summary

02. List of Abbreviations

03. Scope of the Report

04. Product Profiles

05. Market Research Methodology

06. Introduction

07. Rate of Incidence and Prevalence

08. Market Segmentation by Molecule Type

09. Market Segmentation by Route of Administration

10. Geographical Segmentation

11. Buying Criteria

12. Market Growth Drivers

13. Drivers and their Impact

14. Market Challenges

15. Impact of Drivers and Challenges

16. Market Trends

17. Trends and their Impact

18. Vendor Landscape

19. Key Vendor Analysis

20. Other Reports in this Series

Companies Mentioned:

  • Americas
  • APAC
  • EMEA Key Vendors
  • Bayer
  • Biogen Idec
  • Merck Serono
  • Novartis
  • Teva Pharmaceutical
  • AB Science
  • Abbvie
  • Acorda
  • Active Biotech
  • GlaxoSmithKline
  • Glenmark
  • Mitsubishi Tanabe
  • Opexa
  • Pfizer
  • Sanofi

For more information visit http://www.researchandmarkets.com/research/z9b74c/global_multiple

Media Contact: Laura Wood, +353-1-481-1716,

SOURCE Research and Markets
Copyright©2014 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Global Orthopedic Soft Tissue Repair Devices Market 2014-2018: Key Vendors are ArthroCare, Biomet, DePuy Synthes and Smith & Nephew
2. Academy Leaders Publishes Case Study on Work with Global Pharmaceutical Company
3. Radiofrequency Identification (RFID) Market in Healthcare is Expected to Reach USD 5.3 Billion Globally by 2020: Transparency Market Research
4. Gateway Analytical to Promote Particulate Identification Services at the 9th Annual Global Pharma Manufacturing Summit
5. DelMar Pharmaceuticals To Present At The 16th Annual Rodman & Renshaw Global Investment Conference
6. Global Pulse Oximeter Industry Report 2014
7. Global Orthopedic Soft Tissue Repair Devices Market 2014-2018
8. Global Heart Valve Repair and Replacement Market 2014-2018
9. Hill-Rom to Participate in the Morgan Stanley Global Healthcare Conference
10. Global Animal Health Market 2014-2018
11. Columbia Laboratories to participate in the Rodman & Renshaw 16th Annual Global Investment Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/30/2014)...  According to their CEO, Rob Bohacs ... is going through a complete transformation with highly ... the current clinical trial management process isn,t configured ... trials, which will ultimately drive the prescription cancer ... has been recognized by the National Cancer Institute as ...
(Date:9/30/2014)... 2014   Easy Breathe , the fastest growing ... that it now offers the revolutionary AirSense ... first sleep apnea therapy devices with internal cellular modems.  ... track and share real-time data on each user,s quality ... therapy.  In addition, the internal modem allows the CPAP ...
(Date:9/30/2014)... , Sept. 30, 2014 Valeant Pharmaceuticals International, ... today announced that the company,s Bridgewater, New ... the U.S. Food and Drug Administration (FDA) relating to ... with regards to Sculptra Aesthetic injectable, which was divested ... to the management of Valeant,s contract manufacturers (rather than ...
Breaking Medicine Technology:Small Denver Company Pharmatech driving a large revolution in how cancer clinical trials are managed 2Easy Breathe Now Offers World's First "Smart" CPAP Device to Treat Sleep Apnea 2Easy Breathe Now Offers World's First "Smart" CPAP Device to Treat Sleep Apnea 3Easy Breathe Now Offers World's First "Smart" CPAP Device to Treat Sleep Apnea 4Valeant Pharmaceuticals' Bridgewater Location Receives Warning Letter From FDA 2
... Today Brainlab announced the 500th sale of its ... The scale of uptake highlights physicians continued focus on ... their ongoing investment in ensuring access to advanced radiation ... system, first developed almost a decade ago, has been ...
... 16, 2012 On January 9, 2012, Questcor ... from an individual representing herself to be associated ... individual requested that the Company provide responses to ... January 10, 2012.  Due to management,s schedule, the ...
Cached Medicine Technology:Brainlab ExacTrac® System Achieves Major Sales Milestone 2Questcor Pharmaceuticals Responds to Questions From Investor Blog 2Questcor Pharmaceuticals Responds to Questions From Investor Blog 3Questcor Pharmaceuticals Responds to Questions From Investor Blog 4Questcor Pharmaceuticals Responds to Questions From Investor Blog 5Questcor Pharmaceuticals Responds to Questions From Investor Blog 6Questcor Pharmaceuticals Responds to Questions From Investor Blog 7Questcor Pharmaceuticals Responds to Questions From Investor Blog 8Questcor Pharmaceuticals Responds to Questions From Investor Blog 9Questcor Pharmaceuticals Responds to Questions From Investor Blog 10Questcor Pharmaceuticals Responds to Questions From Investor Blog 11Questcor Pharmaceuticals Responds to Questions From Investor Blog 12Questcor Pharmaceuticals Responds to Questions From Investor Blog 13Questcor Pharmaceuticals Responds to Questions From Investor Blog 14Questcor Pharmaceuticals Responds to Questions From Investor Blog 15Questcor Pharmaceuticals Responds to Questions From Investor Blog 16Questcor Pharmaceuticals Responds to Questions From Investor Blog 17
(Date:9/30/2014)... 30, 2014 A new study ... studied the impact of stress on metabolism after eating a ... fries from a fast food restaurant, about 930 calories and ... for 20 minutes every hour for 7 hours, conducting the ... women who had experienced a stressful event in their lives ...
(Date:9/30/2014)... (PRWEB) September 30, 2014 Dynamic ... have hampered growth in the Bread Production industry ... caused consumers to moderate their consumption of a ... for premium varieties shrunk the market for white ... operators proactively responded by introducing more nutritious products ...
(Date:9/30/2014)... Integrated Medicine Alliance , Monmouth County’s ... medical specialty practice through a unique partnership with an ... located within the company’s Shrewsbury location and will be ... of American Heart Center, P.C., a highly regarded practice ... Integrated Medicine Alliance patients top notch cardiovascular care without ...
(Date:9/30/2014)... (FQHCs) granted new patient appointments to Medicaid beneficiaries ... primary care practices (non-FQHCs), in addition to charging ... new 10-state University of Pennsylvania study published this ... data from a previous "secret shopper" study conducted ... FQHCs community health clinics that receive federal ...
(Date:9/30/2014)... 30, 2014 Research by UC Irvine immunologists reveals ... light on a vital process that determines how the ... online version of Nature Immunology , neurology professor ... Institute for Immunology colleagues describe a critical mechanism underlying ... the bloodstream. , A T cell is a type ...
Breaking Medicine News(10 mins):Health News:NutriGold Urges Every Woman To Read a Recent Study About Diet and Stress 2Health News:NutriGold Urges Every Woman To Read a Recent Study About Diet and Stress 3Health News:Bread Production in the US Industry Market Research Report from IBISWorld Has Been Updated 2Health News:Bread Production in the US Industry Market Research Report from IBISWorld Has Been Updated 3Health News:Integrated Medicine Alliance Announces New Cardiology Practice 2Health News:Medicaid and Uninsured patients obtain new patient appointments most easily at FQHCs 2Health News:UCI study uncovers important process for immune system development 2
... April 27 Estill Medical Technologies, Inc., the industry ... announces the expansion of its Thermal Angel sales and ... mortality by quickly controlling core body temperature and infection ... administration. In emergency medicine, the golden hour refers to ...
... Members to Help Raise Obesity on the Nation,s Public ... health associations and obesity experts joined the S ... P revent (STOP) Obesity Alliance today as the organization ... grappling with the high costs of weight-related health conditions ...
... illnesses in which the immune system creates autoantibodies to ... non-profit Autoimmunity Research Foundation (ARF) explain that the antibodies ... human genes and gene products by hidden bacteria. , ... bacteria capable of causing human disease, But DNA discoveries ...
... Pharmaceuticals, a division of Wyeth (NYSE: ... has granted marketing authorization for CONBRIZA(TM) (bazedoxifene), a ... of postmenopausal osteoporosis in women at increased risk ... risk treatment guidelines and assessment tool for calculating ...
... Study shows those who respond to lapatinib survive longer, , , ... be used to treat aggressive inflammatory breast cancer, suggest the ... cancer accounts for up to 6 percent of all invasive ... to the researchers. Symptoms include rapid onset of swelling, ...
... to mirror Mandela,s values NEW YORK, April 27 46664 ... the world to support the creation of an official ... Mr. Mandela,s birthday. This celebration of Nelson Mandela,s life will ... recognize their individual power to make an imprint and help ...
Cached Medicine News:Health News:Thermal Angel Supports Infection Control During the Golden Hour 2Health News:As Health Reform Takes Shape, Leading Medical and Public Health Organizations Join Effort to Keep Obesity Front and Center 2Health News:As Health Reform Takes Shape, Leading Medical and Public Health Organizations Join Effort to Keep Obesity Front and Center 3Health News:As Health Reform Takes Shape, Leading Medical and Public Health Organizations Join Effort to Keep Obesity Front and Center 4Health News:'Autoantibodies' may be created in response to bacterial DNA 2Health News:Wyeth's CONBRIZA Approved in the European Union for Treatment of Postmenopausal Osteoporosis in Women at Increased Risk of Fracture 2Health News:Wyeth's CONBRIZA Approved in the European Union for Treatment of Postmenopausal Osteoporosis in Women at Increased Risk of Fracture 3Health News:Wyeth's CONBRIZA Approved in the European Union for Treatment of Postmenopausal Osteoporosis in Women at Increased Risk of Fracture 4Health News:Drug May Help Against Inflammatory Breast Cancer 2Health News:46664 and the Nelson Mandela Foundation Call for Establishment of Global 'Mandela Day' 2Health News:46664 and the Nelson Mandela Foundation Call for Establishment of Global 'Mandela Day' 3Health News:46664 and the Nelson Mandela Foundation Call for Establishment of Global 'Mandela Day' 4Health News:46664 and the Nelson Mandela Foundation Call for Establishment of Global 'Mandela Day' 5
The VPAP III ST is a complete system solution for SDB, providing comfortable and effective bilevel treatment with additional treatment modes. The VPAP III ST is an effective business solution for cli...
The GoodKnight® 425 Bi-Level® device is suitable for travel and includes features such as automatic altitude compensation, optional cigarette lighter adapter and portable battery pack...
... The BiPAP Pro with Bi-Flex bi-level ... time that the BiPAP Pro takes to ... includes Digital Auto-Trak Sensitivity™ which automatically triggers ... expiratory pressures based on the patients breathing ...
... Electrophoresis System (PGGE) is designed to ... density lipoproteins (LDL) and high density ... using nondenaturing pore gradient gel electrophoresis. ... short DNA sequencing runs. Temperature control ...
Medicine Products: